Bioventus Launches SUPARTZ FX™Now with Expanded Safety Label for Repeat Injection Cycles in Knee Osteoarthritis DURHAM, NC – October 12, 2015 – Bioventus, a global leader in orthobiologics, today announced the launch of SUPARTZ FX™, a broadening of its current